India Issues Guidelines For Reviewing Drug Patent Applications
This article was originally published in PharmAsia News
Executive Summary
India's patent office issued a set of guidelines for examiners to follow in reviewing and granting drug patents in order to bring consistency to the process.
India's patent office issued a set of guidelines for examiners to follow in reviewing and granting drug patents in order to bring consistency to the process. The drug guidelines are separate from those covering patents on other types of products. Along with a large increase in patent applications in recent years has come an increase in patent challenges and litigations. (Click here for more
)
"Government To Revise Patent Norms For Pharma" - Business Standard (India) (8/19/2014)